We are live on
!
Find out more
TAM
Telemark Asset Management Portfolio holdings
AUM
$1.08B
1-Year Est. Return
70.88%
This Fund
S&P 500
This Quarter
Est. Return
+10.49%
1 Year Est. Return
+70.88%
3 Year Est. Return
+270.69%
5 Year Est. Return
+512.18%
10 Year Est. Return
+6,002.69%
AUM
$1.4B
AUM Growth
+$16.5M
(+1.2%)
Cap. Flow
-$47M
Cap. Flow
% of AUM
-3.36%
Top 10 Holdings %
Top 10 Hldgs %
41.29%
Holding
62
New
6
Increased
13
Reduced
17
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$49.5M |
| 2 |
Franco-Nevada
FNV
|
+$34.6M |
| 3 |
Ford
F
|
+$27.6M |
| 4 |
General Motors
GM
|
+$26.3M |
| 5 |
LUCK
Lucky Strike Entertainment
LUCK
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ginkgo Bioworks
DNA
|
+$69.5M |
| 2 |
Moderna
MRNA
|
+$29.2M |
| 3 |
FIVE9
FIVN
|
+$22.2M |
| 4 |
CrowdStrike
CRWD
|
+$19.7M |
| 5 |
Twilio
TWLO
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 28.67% |
| 2 | Technology | 21.28% |
| 3 | Healthcare | 17.05% |
| 4 | Consumer Discretionary | 15.86% |
| 5 | Materials | 4.09% |
Similar funds
FNT
EG
M
CIS
HBCM
ACP
SI
PWA
Telemark Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Telemark Asset Management held 62 positions worth $1.4B, up 1.2% from $1.38B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Telemark Asset Management withdrew a net $47M in Q4 2021, closing 10 positions and reducing 17 holdings. Its most notable exit was Ginkgo Bioworks, an estimated $69.5M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Telemark Asset Management opened a new position in Pfizer worth $59M.
- Telemark Asset Management's largest Q4 2021 buy was Pfizer: 1,000,000 shares worth $59M.
- Telemark Asset Management added most to Lucky Strike Entertainment in Q4 2021, an estimated $23.9M increase.
- Telemark Asset Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $29.2M.
- Telemark Asset Management fully exited Ginkgo Bioworks in Q4 2021, selling an estimated $69.5M.
- Telemark Asset Management's ten largest holdings make up 41% of its $1.4B portfolio in Q4 2021.
- Telemark Asset Management opened 6 new positions and closed 10 in Q4 2021.
- Telemark Asset Management's portfolio value rose 1.2% quarter-over-quarter to $1.4B.
Based on Telemark Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.